Mission Therapeutics Raises $13.3M From Existing Strategic Investors

Deal Summary

Mission Therapeutics, a Cambridge clinical-stage biotech focused on enhancing mitophagy, raised $13.3M in a financing led by its existing investors to advance its therapeutic programs. Lead investors include Pfizer Venture Investments, Sofinnova Partners, Roche Venture Fund, SR One, IP Group and Rosetta Capital.